ArticleBMC musculoskeletal disorders2025
Importance of osteoporosis screening in the perimenopausal age.
Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe level of awareness of Saudi perimenopausal women regarding the importance of osteoporosis screening should be determined, and obstacles that prevent/delay them from doing so should be identified.
methodsThis was a national-level cross-sectional study conducted during the months of September and October 2021. A total of 1716 respondents were women, after men and any woman younger than 40 years were excluded.
resultsParticipants' awareness was identified by five questions, dividing the cohort into three groups. Only 22 (1.3%) participants were completely aware, 12 (0.7%) participants had no idea about screening, and the remaining 1682 (98%) participants were partially aware. The aware group was significantly associated with only being older and already diagnosed with osteoporosis (p < 0.001). The obstacles that prevented participants from performing screening were significantly associated with a lack of doctor advice and requests (p < 0.001) and with participants being worried about other diseases (p < 0.001), age (p < 0.001), level of education (p = 0.013) and monthly income (p < 0.001).
conclusionAlthough osteoporosis is a preventable disease, unfortunately, only 22 (1.3%) participants were fully aware of the importance of osteoporosis screening. Therefore, more efforts are needed from all doctors dealing with perimenopausal women to discuss and screen them.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.